292 related articles for article (PubMed ID: 15300007)
1. The role of Tbx2 and Tbx3 in mammary development and tumorigenesis.
Rowley M; Grothey E; Couch FJ
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):109-18. PubMed ID: 15300007
[TBL] [Abstract][Full Text] [Related]
2. The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer.
Douglas NC; Papaioannou VE
J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):143-7. PubMed ID: 23624936
[TBL] [Abstract][Full Text] [Related]
3. Short communication: Expression of T-box 2 and 3 in the bovine mammary gland.
Hoffman ML; McFadden KK; Hoagland TA; Kazmer GW; Govoni KE
J Dairy Sci; 2014 Jul; 97(7):4322-8. PubMed ID: 24767885
[TBL] [Abstract][Full Text] [Related]
4. Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos.
Eblaghie MC; Song SJ; Kim JY; Akita K; Tickle C; Jung HS
J Anat; 2004 Jul; 205(1):1-13. PubMed ID: 15255957
[TBL] [Abstract][Full Text] [Related]
5. Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.
Jerome-Majewska LA; Jenkins GP; Ernstoff E; Zindy F; Sherr CJ; Papaioannou VE
Dev Dyn; 2005 Dec; 234(4):922-33. PubMed ID: 16222716
[TBL] [Abstract][Full Text] [Related]
6. TBX2 and TBX3: the special value for anticancer drug targets.
Lu J; Li XP; Dong Q; Kung HF; He ML
Biochim Biophys Acta; 2010 Dec; 1806(2):268-74. PubMed ID: 20624445
[TBL] [Abstract][Full Text] [Related]
7. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator.
Lingbeek ME; Jacobs JJ; van Lohuizen M
J Biol Chem; 2002 Jul; 277(29):26120-7. PubMed ID: 12000749
[TBL] [Abstract][Full Text] [Related]
8. TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.
Platonova N; Scotti M; Babich P; Bertoli G; Mento E; Meneghini V; Egeo A; Zucchi I; Merlo GR
Cell Tissue Res; 2007 May; 328(2):301-16. PubMed ID: 17265068
[TBL] [Abstract][Full Text] [Related]
9. TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.
Liu J; Esmailpour T; Shang X; Gulsen G; Liu A; Huang T
BMC Dev Biol; 2011 Oct; 11():65. PubMed ID: 22039763
[TBL] [Abstract][Full Text] [Related]
10. A crucial role for fibroblast growth factor signaling in embryonic mammary gland development.
Dillon C; Spencer-Dene B; Dickson C
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):207-15. PubMed ID: 15300014
[TBL] [Abstract][Full Text] [Related]
11. The T-box transcription factor Tbx2: its role in development and possible implication in cancer.
Abrahams A; Parker MI; Prince S
IUBMB Life; 2010 Feb; 62(2):92-102. PubMed ID: 19960541
[TBL] [Abstract][Full Text] [Related]
12. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines.
Fan W; Huang X; Chen C; Gray J; Huang T
Cancer Res; 2004 Aug; 64(15):5132-9. PubMed ID: 15289316
[TBL] [Abstract][Full Text] [Related]
13. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
14. Expression and requirement of T-box transcription factors Tbx2 and Tbx3 during secondary palate development in the mouse.
Zirzow S; Lüdtke TH; Brons JF; Petry M; Christoffels VM; Kispert A
Dev Biol; 2009 Dec; 336(2):145-55. PubMed ID: 19769959
[TBL] [Abstract][Full Text] [Related]
15. TBX3 and its splice variant TBX3 + exon 2a are functionally similar.
Hoogaars WM; Barnett P; Rodriguez M; Clout DE; Moorman AF; Goding CR; Christoffels VM
Pigment Cell Melanoma Res; 2008 Jun; 21(3):379-87. PubMed ID: 18444963
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling in mammary development and oncogenesis.
Callahan R; Egan SE
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):145-63. PubMed ID: 15300010
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.
Mesbah K; Rana MS; Francou A; van Duijvenboden K; Papaioannou VE; Moorman AF; Kelly RG; Christoffels VM
Hum Mol Genet; 2012 Mar; 21(6):1217-29. PubMed ID: 22116936
[TBL] [Abstract][Full Text] [Related]
18. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
19. Msx-1 and Msx-2 in mammary gland development.
Satoh K; Ginsburg E; Vonderhaar BK
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):195-205. PubMed ID: 15300013
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions between Tbx3 and Bmp4 and a model for dorsoventral positioning of mammary gland development.
Cho KW; Kim JY; Song SJ; Farrell E; Eblaghie MC; Kim HJ; Tickle C; Jung HS
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16788-93. PubMed ID: 17071745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]